Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 8/20 | 0.45 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | CACNA1H | O95180 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | PRKCI | P41743 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31369456 | 0.89 | FAAH (0.46) | S1PR1FAAHOXER1CYP2A6CA1 | |
| SCHEMBL31369499 | 0.86 | CHRNA7 (0.52) | FAAHCHRNA7CYP2A6TRPV1 | |
| SCHEMBL6487657 | 0.84 | OXER1 (0.51) | S1PR1FAAHCHRNA7OXER1CYP2A6 | |
| SCHEMBL31036052 | 0.78 | MTNR1A (0.52) | S1PR1FAAHCHRNA7TP53TRPV1 | |
| SCHEMBL5094204 | 0.78 | KDM4E (0.58) | FAAHCHRNA7CYP2A6TRPV1CACNA1H | |
| SCHEMBL22657420 | 0.76 | FAAH (0.47) | FAAHCHRNA7CYP2A6TP53TRPV1 | |
| SCHEMBL31036025 | 0.76 | HPGD (0.53) | S1PR1CHRNA7TP53TRPV1 | |
| SCHEMBL28839373 | 0.75 | CHRNA7 (0.49) | FAAHCHRNA7CYP2A6TRPV1CACNA1H | |
| SCHEMBL31370404 | 0.75 | FAAH (0.47) | FAAHCHRNA7OXER1CYP2A6TRPV1 | |
| SCHEMBL30046101 | 0.75 | PRKCI (0.50) | FAAHCHRNA7CYP2A6TRPV1CACNA1H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | S1PR1 4882/4885FAAH 4657/4885CHRNA7 4697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.